A new class of life-saving drugs is helping children who once had no hope. But some carry a price tag of millions for a ...
The patchwork rollout of a gene therapy exposes weaknesses in the pricing and regulatory frameworks that determine who ...
The European Society of Human Reproduction and Embryology has also proposed an immediate limit of 50 families per donor ...
Findings from two clinical trials suggest Novartis' Itvisma is safe and effective for SMA patients over two years old.
Using CRISPR, researchers have modelled the different developmental stages of childhood leukaemia. They discovered that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback